|
- JAN 21
- Sachiyo Kanai (Pharmacology Division)
Anti-tumor effect of a-galactosylceramide-activated NKT cells after G-CSF mobilization
- Satoshi Yamashita (Carcinogenesis Division)
Isolation and analysis of differentially expressed genes in the pylorus of two rat strains which have different susceptibilities to gastric cancer
- FEB 18
- Akio Ashida (Genetics Division)
Microarray analysis of esophageal cancer
Kimiko Shimizu (Cancer Genomics Division)
Genetic predisposition associated with susceptibility to human leukemia
- MAR18
- Hiroko Yaguchi (Growth Factor Division)
Function of the multiple endocrine neoplasia type 1 (MEN1) gene
Tomoaki Tanaka (Radiobiology Division)
DNA damage-responsive p53 serine 46 kinase complex contains casein kinase 2 and p53Dinp1
- APR 15
- Koji Okada (Radiobiology Division)
Regulation of p53 activity by phosphorylation of Mdm2
Yoshiyuki Ishii (Investigative Treatment Division)
Roles of nitric oxide in tumor invasion and metastasis
- MAY 20
- Michiho Nishioka (Biology Division)
Isolation of a candidate tumor suppressor gene, MYO18B, associated with lung cancer progression
Tomoyuki Hanaoka (Epidemiology and Biostatistics Division)
Evaluation of a dietary intervention trial by urinary etheno DNA base adducts
- JUN 17
- Mami Takahashi (Cancer Prevention Division)
Gene mutations and alteration of protein expression in rat colon carcinogenesis
Takahiro Ochiya (Section for Studies on Metastasis)
Atelocollagen-mediated cell transfection array for cancer gene therapy
- JUL 15
- Yae Kanai (Pathology Division)
Alteration of DNA methylation in multistage carcinogenesis
Kyoko Fujiwara (Biochemistry Division)
Discussion of multistep colon carcinogenesis induced by PhIP in rats
- SEP 9
- Hiroo Ueno (Virology Division)
Application of retrovirus-mediated expression cloning: Identification of hematopoiesis-associated genes from bone marrow stromal cells
Shigeki Sekine (Pathology Division)
"Targeted disruption of the mutant b-catenin gene in a colon cancer cell line/ Mutational analyses of the b-catenin gene in human tumors"
- OCT 21
- Mari Masuda (Tumor Suppression and Functional Genomics Project)
The tumor suppressor TSLC1 protein is involved in cell-cell adhesion
Haruhiko Fukuda (Cancer Information and Epidemiology Division)
Clinical trial methodology for the development of target-based oncology drugs
- NOV 18
- Shizuka Sasazuki (Epidemiology and Biostatistics Division)
Cigarette smoking, alcohol consumption, and subsequent gastric cancer risk by subsite and histo-logic type -results from 10-year follow up of JPHC Study-
Masahiko Shiraishi (DNA Methylation and Genome Function Project)
CpG island methylation, histone modification, inactive chromatin, and human cancer
|
|
